Dr. Marcos Ignacio Restrepo, MD, MSC

2017 Medicare Procedure Volume

The top procedures that Dr. Marcos Ignacio Restrepo, MD, MSC treated as a pulmonologist in Temple, TX during 2017 were hospital care and inpatient care.

Volume of procedures performed by Dr. Marcos Ignacio Restrepo, MD, MSC for Medicare patients.

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Marcos Ignacio Restrepo, MD, MSC.

Conditions of Medicare patients treated by Dr. Marcos Ignacio Restrepo, MD, MSC in 2017

The most common conditions of Medicare patients that Dr. Marcos Ignacio Restrepo, MD, MSC treated during 2017 were chronic kidney disease, chronic obstructive pulmonary disease, heart failure and hypertension.

2018 Medicare Procedure Volume

The top procedures that Dr. Marcos Ignacio Restrepo, MD, MSC treated as a pulmonologist in Temple, TX during 2018 were hospital care and inpatient care.

Volume of procedures performed by Dr. Marcos Ignacio Restrepo, MD, MSC for Medicare patients.

Conditions of Medicare patients treated by Dr. Marcos Ignacio Restrepo, MD, MSC in 2018

The most common conditions of Medicare patients that Dr. Marcos Ignacio Restrepo, MD, MSC treated during 2018 were chronic kidney disease, chronic obstructive pulmonary disease, heart failure and hypertension.

Average Medicare Procedure Volume From 2017 - 2018

Volume of procedures performed by Dr. Marcos Ignacio Restrepo, MD, MSC for Medicare patients.

The highest averages for the top procedures that Dr. Marcos Ignacio Restrepo, MD, MSC treated as a pulmonologist in Temple, TX were hospital care and inpatient care.

Average Medicare Patient Data From 2017 - 2018

Information about Medicare patients treated by Dr. Marcos Ignacio Restrepo, MD, MSC.

Average of Total of Conditions of Medicare patients treated by Dr. Marcos Ignacio Restrepo, MD, MSC From 2017 - 2018

The highest averages of the most common conditions of Medicare patients that Dr. Marcos Ignacio Restrepo, MD, MSC treated were chronic kidney disease, chronic obstructive pulmonary disease, heart failure and high cholesterol.